Properties (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Otsuka_Pharmaceutical_in_2008
|
| gptkbp:annualVisitors |
over $1 billion
|
| gptkbp:awards |
various industry awards
|
| gptkbp:clinicalTrials |
ongoing
in multiple therapeutic areas |
| gptkbp:collaborations |
with universities
with biotech companies |
| gptkbp:communityPrograms |
disaster relief efforts
health education support for patients |
| gptkbp:corporateSocialResponsibility |
community engagement
environmental sustainability healthcare_initiatives |
| gptkbp:employeeCount |
over 1,000
|
| gptkbp:founded |
1963
|
| gptkbp:founder |
gptkb:Masayuki_Matsumoto
|
| gptkbp:globalPresence |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:headquarters |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Taiho Pharmaceutical
|
| gptkbp:investmentFocus |
in innovative therapies
|
| gptkbp:leadership |
experienced management team
|
| gptkbp:market |
gptkb:Japan
international markets new drugs annually |
| gptkbp:mission |
develop innovative medicines
|
| gptkbp:parentCompany |
gptkb:Otsuka_Pharmaceutical
|
| gptkbp:partnerships |
various research institutions
|
| gptkbp:patentCitation |
numerous patents in pharmaceuticals
|
| gptkbp:products |
therapeutic agents
anti-cancer drugs diagnostic_agents |
| gptkbp:regulatoryCompliance |
multiple countries
|
| gptkbp:researchAndDevelopment |
significant investment
|
| gptkbp:researchFocus |
biologics
small molecules |
| gptkbp:specializesIn |
oncology
urology gastroenterology |
| gptkbp:sustainability |
reduce carbon footprint
promote health and well-being increase renewable energy use |
| gptkbp:values |
gptkb:collaboration
respect integrity excellence |
| gptkbp:vision |
improve patient outcomes
|
| gptkbp:website |
www.taiho.co.jp
|